US6131575A
(en)
*
|
1991-01-10 |
2000-10-17 |
The Procter & Gamble Company |
Urinary incontinence device
|
WO1996000072A1
(en)
*
|
1994-06-23 |
1996-01-04 |
The Procter & Gamble Company |
Treatment of nicotine craving and/or smoking withdrawal symptoms with a transdermal or transmucosal composition containing nicotine and caffeine or xanthine
|
DE19517145C2
(en)
*
|
1995-05-10 |
2000-02-24 |
Hexal Pharmaforschung Gmbh |
Transdermal therapeutic system (TTS) for administration of testosterone
|
US6245347B1
(en)
*
|
1995-07-28 |
2001-06-12 |
Zars, Inc. |
Methods and apparatus for improved administration of pharmaceutically active compounds
|
US5980948A
(en)
*
|
1996-08-16 |
1999-11-09 |
Osteotech, Inc. |
Polyetherester copolymers as drug delivery matrices
|
DE19649534B4
(en)
|
1996-11-29 |
2004-05-06 |
Lts Lohmann Therapie-Systeme Ag |
Packing made of composite packaging for packaging active ingredient-containing patches
|
AU735944B2
(en)
*
|
1997-02-28 |
2001-07-19 |
Minnesota Mining And Manufacturing Company |
Transdermal device for the delivery of testosterone
|
US6691872B1
(en)
|
1997-04-08 |
2004-02-17 |
Aki, Inc. |
Method of making a cosmetic sampler using bulk thin film application techniques
|
US5953885A
(en)
*
|
1997-04-08 |
1999-09-21 |
Retail Communications Corp. |
Cosmetic sampler and method of making using bulk thin film application techniques
|
US6261405B1
(en)
|
1997-06-27 |
2001-07-17 |
Noven Pharmaceuticals, Inc. |
Method and apparatus for making a patch
|
DE19728517C2
(en)
*
|
1997-07-04 |
1999-11-11 |
Sanol Arznei Schwarz Gmbh |
TTS for the administration of sex steroid hormones and process for its preparation
|
DE19728516C2
(en)
*
|
1997-07-04 |
1999-11-11 |
Sanol Arznei Schwarz Gmbh |
TTS for administration of levonorgestrel and possibly estradiol
|
US20020012694A1
(en)
*
|
1997-09-17 |
2002-01-31 |
Alfred J. Moo-Young |
Transdermal administration of ment
|
US6767902B2
(en)
|
1997-09-17 |
2004-07-27 |
The Population Council, Inc. |
Androgen as a male contraceptive and non-contraceptive androgen replacement
|
ES2226205T3
(en)
|
1997-12-19 |
2005-03-16 |
Taro Pharmaceuticals U.S.A., Inc. |
TOPIC FORMULATIONS OF CARBAMAZEPINE AND PROCEDURE OF USE.
|
US7491232B2
(en)
*
|
1998-09-18 |
2009-02-17 |
Aptus Endosystems, Inc. |
Catheter-based fastener implantation apparatus and methods with implantation force resolution
|
DE19821788C1
(en)
*
|
1998-05-15 |
1999-12-02 |
Sanol Arznei Schwarz Gmbh |
Transdermal therapeutic system (TTS) containing pergolide
|
CA2345492C
(en)
*
|
1998-09-29 |
2009-12-22 |
Zars, Inc. |
Methods and apparatus for improved administration of pharmaceutically active compounds
|
US6475514B1
(en)
|
1998-12-03 |
2002-11-05 |
Andrew Blitzer |
Athletic patch
|
DK1140039T3
(en)
|
1998-12-18 |
2010-03-22 |
Alza Corp |
Transparent devices for percutaneous nicotine administration
|
US6270781B1
(en)
|
1999-01-08 |
2001-08-07 |
Maxim Pharmaceuticals, Inc. |
Method and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors
|
US6242473B1
(en)
|
1999-01-08 |
2001-06-05 |
Maxim Pharmaceuticals, Inc. |
Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
|
US6274168B1
(en)
*
|
1999-02-23 |
2001-08-14 |
Mylan Pharmaceuticals Inc. |
Phenytoin sodium pharmaceutical compositions
|
ATE302598T1
(en)
*
|
1999-04-01 |
2005-09-15 |
Alza Corp |
TRANSDERMAL DRUG ADMINISTRATION DEVICE HAVING A POLYURETHANE DRUG RESERVOIR
|
US6417227B1
(en)
|
1999-04-28 |
2002-07-09 |
Cg And Associates |
Methods of delivery of cetyl myristoleate
|
US6733785B1
(en)
*
|
1999-06-11 |
2004-05-11 |
Lintec Corporation |
Moisture-sensitive preparation of percutaneous absorption type
|
FR2795326B1
(en)
*
|
1999-06-28 |
2001-08-31 |
Adir |
SOLID THERMOFORMABLE PHARMACEUTICAL COMPOSITION WITH CONTROLLED RELEASE
|
DE10001546A1
(en)
*
|
2000-01-14 |
2001-07-19 |
Beiersdorf Ag |
Process for the continuous production and coating of self-adhesive compositions based on polyisobutylene with at least one active pharmaceutical ingredient
|
US20020004065A1
(en)
|
2000-01-20 |
2002-01-10 |
David Kanios |
Compositions and methods to effect the release profile in the transdermal administration of active agents
|
DE10018834A1
(en)
*
|
2000-04-15 |
2001-10-25 |
Lohmann Therapie Syst Lts |
Transdermal or transmucosal pharmaceutical dosage form for treatment of nicotine dependence or smoking withdrawal contains nicotine compound or substitute and CNS active compound
|
US6682757B1
(en)
|
2000-11-16 |
2004-01-27 |
Euro-Celtique, S.A. |
Titratable dosage transdermal delivery system
|
KR100860822B1
(en)
*
|
2000-12-21 |
2008-09-30 |
주식회사 엘지생활건강 |
Patch having sterilizing and disinfective power and for decomposition
|
DE10110391A1
(en)
|
2001-03-03 |
2002-09-26 |
Lohmann Therapie Syst Lts |
Highly flexible nicotine transdermal therapeutic system with nicotine as active ingredient
|
CA2446619C
(en)
*
|
2001-05-11 |
2011-04-26 |
Elan Corporation, Plc |
Permeation enhancers
|
US7968119B2
(en)
*
|
2001-06-26 |
2011-06-28 |
Farrell John J |
Tamper-proof narcotic delivery system
|
US20030014947A1
(en)
*
|
2001-07-19 |
2003-01-23 |
Sarojini Deevi |
Laminated metal foil packaging material and method of making
|
IL160928A0
(en)
*
|
2001-10-19 |
2004-08-31 |
Maxim Pharm Inc |
Use of histamine to treat liver disease
|
JP2005508366A
(en)
*
|
2001-11-06 |
2005-03-31 |
マキシム ファーマシューティカルス,インコーポレイテッド |
Composition for the treatment of infectious diseases
|
US20050177092A1
(en)
*
|
2002-04-25 |
2005-08-11 |
Hirotoshi Adachi |
Apparatus and assembly for administering antimicrobial agent
|
AR033748A1
(en)
*
|
2002-05-15 |
2004-01-07 |
Thalas Group Inc |
A DEVICE FOR THE TRANSDERMAL ADMINISTRATION OF PHARMACOLOGICALLY ACTIVE SUBSTANCES THAT INCLUDES TWO SUPERPOSED ADHESIVE LAYERS AND A PROCEDURE TO PREPARE IT
|
DE10317692A1
(en)
*
|
2003-04-17 |
2004-11-11 |
Lts Lohmann Therapie-Systeme Ag |
Medical active substance patches with reduced optical conspicuity on the skin
|
US7276246B2
(en)
*
|
2003-05-09 |
2007-10-02 |
Cephalon, Inc. |
Dissolvable backing layer for use with a transmucosal delivery device
|
US7306812B2
(en)
|
2003-05-09 |
2007-12-11 |
Cephalon, Inc. |
Dissolvable backing layer for use with a transmucosal delivery device
|
US8524272B2
(en)
*
|
2003-08-15 |
2013-09-03 |
Mylan Technologies, Inc. |
Transdermal patch incorporating active agent migration barrier layer
|
US20050037194A1
(en)
*
|
2003-08-15 |
2005-02-17 |
Kimberly-Clark Worldwide, Inc. |
Thermoplastic polymers with thermally reversible and non-reversible linkages, and articles using same
|
US7122052B2
(en)
*
|
2003-09-29 |
2006-10-17 |
Stout Medical Group Lp |
Integral support stent graft assembly
|
RU2356580C2
(en)
*
|
2003-10-28 |
2009-05-27 |
Новен Фармасьютикалз, Инк |
Compositions and methods providing controlled drug loss and delivery within transdermal drug delivery systems
|
WO2005060960A2
(en)
*
|
2003-12-11 |
2005-07-07 |
Maxim Pharmaceuticals, Inc. |
Use of histamine to treat bone disease
|
US8142603B2
(en)
†
|
2004-03-26 |
2012-03-27 |
Csp Technologies, Inc. |
Active film adhered to flexible packages and method thereof
|
US20050221036A1
(en)
*
|
2004-04-01 |
2005-10-06 |
The Coca-Cola Company |
Polyester composition with enhanced gas barrier, articles made therewith, and methods
|
AU2005245407B9
(en)
*
|
2004-05-12 |
2010-10-14 |
E.I. Dupont De Nemours And Company |
Films comprising a liquid-absorbant inner layer, an antimicrobial material and an impermeable outer layer
|
US20060002913A1
(en)
*
|
2004-06-22 |
2006-01-05 |
Gehlsen Kurt R |
Use of histamine and related compounds to treat disorders affecting muscle function
|
EP1812001A2
(en)
*
|
2004-10-21 |
2007-08-01 |
The Trustees Of Columbia University In The City Of New York |
Nicotinic-opioid synergy for analgesia
|
US10016385B2
(en)
|
2004-12-17 |
2018-07-10 |
Alan B. Cash |
Method for extending lifespan delaying the onset of age-related disease
|
US8545952B2
(en)
*
|
2005-06-07 |
2013-10-01 |
The Coca-Cola Company |
Polyester container with enhanced gas barrier and method
|
US7820258B2
(en)
*
|
2005-10-05 |
2010-10-26 |
The Coca-Cola Company |
Container and composition for enhanced gas barrier properties
|
US20070087055A1
(en)
*
|
2005-10-14 |
2007-04-19 |
David Jan |
Directly compressible extended release alprazolam formulation
|
DE102006026060B4
(en)
*
|
2006-01-12 |
2013-01-31 |
Lts Lohmann Therapie-Systeme Ag |
Transdermal therapeutic system containing as active ingredient nicotine and method for producing such systems
|
US7740879B2
(en)
*
|
2006-01-17 |
2010-06-22 |
Harrogate Holdings |
Abuse resistant transdermal drug delivery patch
|
MX2008012264A
(en)
|
2006-03-24 |
2009-02-20 |
Auxilium Int Holdings Inc |
Stabilized compositions containing alkaline labile drugs.
|
US8465759B2
(en)
|
2006-03-24 |
2013-06-18 |
Auxilium Us Holdings, Llc |
Process for the preparation of a hot-melt extruded laminate
|
GB2438926A
(en)
*
|
2006-06-07 |
2007-12-12 |
Paul Marshall |
Transdermal patch
|
US8124202B2
(en)
*
|
2006-09-15 |
2012-02-28 |
The Coca-Cola Company |
Multilayer container for enhanced gas barrier properties
|
US7790077B2
(en)
*
|
2006-09-15 |
2010-09-07 |
The Coca-Cola Company |
Pressurized tooling for injection molding and method of using
|
DE102006050558B4
(en)
*
|
2006-10-26 |
2009-03-26 |
Lts Lohmann Therapie-Systeme Ag |
Transdermal therapeutic system containing norelgestromin for contraception and hormone replacement
|
KR100860824B1
(en)
*
|
2007-07-25 |
2008-09-30 |
주식회사 엘지생활건강 |
Patch having sterilizing and disinfective power and for decomposition
|
EP2291181B9
(en)
|
2008-04-18 |
2013-09-11 |
University College Dublin National University Of Ireland, Dublin |
Captodiamine for the treatment of depression symptoms
|
US20100221313A1
(en)
*
|
2008-12-01 |
2010-09-02 |
Innovative Pharmaceuticals, Llc |
Transdermal reservoir patch
|
CA2757302A1
(en)
*
|
2009-04-01 |
2010-10-07 |
Andrew Crockett |
Methods for treating myofascial, muscle, and/or back pain
|
US9186273B2
(en)
*
|
2009-05-04 |
2015-11-17 |
Nuvo Research Inc. |
Methods of treating pains associated with neuroma, nerve entrapment, and other conditions
|
US9186334B2
(en)
|
2009-05-04 |
2015-11-17 |
Nuvo Research Inc. |
Heat assisted lidocaine and tetracaine for transdermal analgesia
|
EP2456839A1
(en)
|
2009-07-21 |
2012-05-30 |
Mylan Inc. |
Process for the continuous manufacture of a polyisobutylene based transdermal patch
|
KR101955175B1
(en)
|
2010-04-13 |
2019-03-06 |
나지브 바불 |
Dermal pharmaceutical compositions of 1-methyl-2'-6'-pipecoloxylidide and method of use
|
DE102010064358A1
(en)
*
|
2010-12-29 |
2012-07-05 |
Acino Ag |
Transdermal application system with protruding baking foil
|
FR2992325B1
(en)
*
|
2012-06-26 |
2015-05-22 |
Ab7 Innovation |
MULTIFUNCTIONAL POLYURETHANE MONOPOLYMERIC MULTIFUNCTION SEQUENCE MATRIX AND MANUFACTURING METHOD
|
EP2682113B1
(en)
*
|
2012-07-02 |
2018-10-31 |
Luye Pharma AG |
Sealing laminates containing agents
|
US9375417B2
(en)
|
2014-12-04 |
2016-06-28 |
Mary's Medicinals LLC |
Transdermal cannabinoid formulations
|
US10028904B2
(en)
|
2014-12-04 |
2018-07-24 |
Wisconsin Alumni Research Foundation |
Transdermal cannabinoid formulations
|
US20170291020A1
(en)
*
|
2016-04-12 |
2017-10-12 |
Mylan Inc. |
Double disk transdermal system
|
US10653639B2
(en)
|
2016-05-16 |
2020-05-19 |
Cv Sciences, Inc. |
Pharmaceutical formulations containing cannabidiol and nicotine for treating smokeless tobacco addiction
|
ES2950096T3
(en)
|
2016-09-22 |
2023-10-05 |
Alan B Cash |
Method to relieve the symptoms of premenstrual syndrome
|
KR101892270B1
(en)
*
|
2017-04-07 |
2018-08-27 |
주식회사 삼양사 |
Patch system for transdermal absorption with minimized skin irritation
|
CN116963728A
(en)
|
2021-01-14 |
2023-10-27 |
A·B·卡什 |
Treatment of pathological fatigue with oxaloacetate
|